Efficacy of Ketamine Infusion Compared With Traditional Anti-epileptic Agents in Refractory Status Epilepticus

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2017
The study will investigate the efficacy of the N-methyl-D-aspartate receptor antagonist ketamine as a first line agent in refractory status epilepticus versus traditional general anesthetic agents used for burst suppression that target the gamma-aminobutyric acid adrenergic receptors.
Epistemonikos ID: 277e98cf9d845a95f2f1e3d84135f7a0489026b0
First added on: May 20, 2024